Open AccessHigh Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children
Author(s) -
Sarah BenkiNugent,
Ira Martopullo,
Tony Laboso,
Nancy Tamasha,
Dalton Wamalwa,
Kenneth Tapia,
Agnes Langat,
Elizabeth MalecheObimbo,
Christina M. Marra,
Paul Bangirana,
Michael J. Boivin,
Grace JohnStewart
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000001979
Subject(s) - neurocognitive , human immunodeficiency virus (hiv) , medicine , pediatrics , immunology , cognition , psychiatry
Monocyte activation may contribute to neuronal injury in aviremic HIV-infected adults; data are lacking in children. We examined the relation between monocyte activation markers and early and long-term neurodevelopmental outcomes in early-treated HIV-infected children.